Literature DB >> 3347272

The iscom antigen-presenting system.

B Morein1.   

Abstract

The immunostimulating complex, or iscom, provides an effective means of presenting antigens to the immune system. Vaccines for influenza, hepatitis B and AIDS are in the offing.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3347272     DOI： 10.1038/332287a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


  8 in total

1.  Immunogenic properties of ISCOM prepared with influenza virus nucleoprotein.

Authors:  H P Weiss; L Stitz; H Becht
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 2.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 3.  Vaccines for control of AIDS--an update.

Authors:  K B Sharma
Journal:  Indian J Pediatr       Date:  1994 Sep-Oct       Impact factor: 1.967

4.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

5.  Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice.

Authors:  F G Araujo; B Morein
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

6.  Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes.

Authors:  K Scheepers; H Becht
Journal:  Med Microbiol Immunol       Date:  1994-11       Impact factor: 3.402

7.  Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus.

Authors:  M K Ijaz; S K Attah-Poku; M J Redmond; M D Parker; M I Sabara; P Frenchick; L A Babiuk
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

8.  Macromolecular assemblage in the design of a synthetic AIDS vaccine.

Authors:  J P Defoort; B Nardelli; W Huang; D D Ho; J P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.